Clinical Trial: Study of CM559 in Healthy Subjects

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175506) titled 'Study of CM559 in Healthy Subjects' on Sept. 05.

Brief Summary: This study is a single center, randomized, double-blind, placebo-controlled, single dose, dose escalation Phase I clinical study aimed at evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of CM559 administered intravenously at different doses in healthy male subjects.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: Placebo

Placebo injection administered IV, once.

BIOLOGICAL: CM559

CM559 injection administered IV, once.

Recruitment Status: NOT_YET_RECRUITING

Spo...